Shah Rukh Khan `s much-awaited film `My Name Is Khan` will see its world premiere in Abu Dhabi next week.
The film, which marks the return of the famous onscreen pair Shah Rukh and Kajol after a gap of eight years, is a love-story in the backdrop of post 9/11 America.
Directed by Karan Johar and co-produced by Khan, the film will premiere in Abu Dhabi on February 10 followed by an European premiere in Berlin two days later.
Thousands of fans are expected to descend on the Emirates Palace hotel in the capital to catch a glimpse of the 44-year-old star, who has a huge fan following in the country.
In the movie, Khan plays Rizwan, a man suffering from Asperger`s syndrome (a form of autism), who embarks on an extraordinary journey across America to win back the love of his life, Mandira (Kajol).
`My Name Is Khan` is one of the first Bollywood films to be distributed by Fox Searchlight Pictures in the US.
Imagenation Abu Dhabi is in a partnership with Fox Star studios to distribute the film in the Middle East.
The film will see its worldwide release on February 12.
The film, which marks the return of the famous onscreen pair Shah Rukh and Kajol after a gap of eight years, is a love-story in the backdrop of post 9/11 America.
Directed by Karan Johar and co-produced by Khan, the film will premiere in Abu Dhabi on February 10 followed by an European premiere in Berlin two days later.
Thousands of fans are expected to descend on the Emirates Palace hotel in the capital to catch a glimpse of the 44-year-old star, who has a huge fan following in the country.
In the movie, Khan plays Rizwan, a man suffering from Asperger`s syndrome (a form of autism), who embarks on an extraordinary journey across America to win back the love of his life, Mandira (Kajol).
`My Name Is Khan` is one of the first Bollywood films to be distributed by Fox Searchlight Pictures in the US.
Imagenation Abu Dhabi is in a partnership with Fox Star studios to distribute the film in the Middle East.
The film will see its worldwide release on February 12.
0 comments:
Post a Comment